Willsher PC - Search Results

1

Prognostic significance of serum c-erbB-2 protein in breast cancer patients.

Willsher PC, Beaver J, Pinder S, Bell JA, Ellis IO, Blamey RW, Robertson JF. Willsher PC, et al. Breast Cancer Res Treat. 1996;40(3):251-5. doi: 10.1007/BF01806813. Breast Cancer Res Treat. 1996. PMID: 8883967

2

Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.

Gee JM, Ellis IO, Robertson JF, Willsher P, McClelland RA, Hewitt KN, Blamey RW, Nicholson RI. Gee JM, et al. Int J Cancer. 1995 Aug 22;64(4):269-73. doi: 10.1002/ijc.2910640410. Int J Cancer. 1995. PMID: 7657391

3

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.

Gee JM, Robertson JF, Ellis IO, Willsher P, McClelland RA, Hoyle HB, Kyme SR, Finlay P, Blamey RW, Nicholson RI. Gee JM, et al. Int J Cancer. 1994 Dec 1;59(5):619-28. doi: 10.1002/ijc.2910590508. Int J Cancer. 1994. PMID: 7960234

4

Serum tissue polypeptide specific antigen (TPS) in breast cancer patients: comparison with CA 15.3 and CEA.

Willsher PC, Beaver J, Blamey RW, Robertson JF. Willsher PC, et al. Anticancer Res. 1995 Jul-Aug;15(4):1609-11. Anticancer Res. 1995. PMID: 7654057

5

The significance of p53 autoantibodies in the serum of patients with breast cancer.

Willsher PC, Pinder SE, Robertson L, Nicholson RI, Ellis IO, Bell JA, Blamey RW, Green JA, Robertson JF. Willsher PC, et al. Anticancer Res. 1996 Mar-Apr;16(2):927-30. Anticancer Res. 1996. PMID: 8687153

6

Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology.

Poole GH, Willsher PC, Pinder SE, Robertson JF, Elston CW, Blamey RW. Poole GH, et al. Among authors: willsher pc. Aust N Z J Surg. 1996 Sep;66(9):592-4. doi: 10.1111/j.1445-2197.1996.tb00825.x. Aust N Z J Surg. 1996. PMID: 8859156

7

A comparison outcome of male breast cancer with female breast cancer.

Willsher PC, Leach IH, Ellis IO, Bourke JB, Blamey RW, Robertson JF. Willsher PC, et al. Am J Surg. 1997 Mar;173(3):185-8. doi: 10.1016/s0002-9610(97)89592-x. Am J Surg. 1997. PMID: 9124623

8

Male breast cancer: pathological and immunohistochemical features.

Willsher PC, Leach IH, Ellis IO, Bell JA, Elston CW, Bourke JB, Blamey RW, Robertson JF. Willsher PC, et al. Anticancer Res. 1997 May-Jun;17(3C):2335-8. Anticancer Res. 1997. PMID: 9245247

9

Predictors of response to second-line endocrine therapy for breast cancer.

Cheung KL, Willsher PC, Pinder SE, Ellis IO, Elston CW, Nicholson RI, Blamey RW, Robertson JF. Cheung KL, et al. Among authors: willsher pc. Breast Cancer Res Treat. 1997 Sep;45(3):219-24. doi: 10.1023/a:1005828731462. Breast Cancer Res Treat. 1997. PMID: 9386865

10

The clinical relevance of static disease (no change) category for 6 months on endocrine therapy in patients with breast cancer.

Robertson JF, Willsher PC, Cheung KL, Blamey RW. Robertson JF, et al. Among authors: willsher pc. Eur J Cancer. 1997 Oct;33(11):1774-9. doi: 10.1016/s0959-8049(97)00178-0. Eur J Cancer. 1997. PMID: 9470831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters